The influence of chronic periodontitis on serum TNF-α, IL-6 and hs-CRP concentrations, and function of graft and survival of kidney transplant recipients

Clinical Transplantation

Volumn 23, Issue 2, 2009, Pages 213-219

  Blach, Anna ^a   Franek, Edward ^b,c   Witula, Artur ^a   Kolonko, Aureliusz ^a   Chudek, Jerzy ^a   Drugacz, Jan ^a   Wiecek, Andrzej ^c  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b CENTRAL CLINICAL HOSPITAL OF THE MINISTRY OF INTERIOR   (Poland)

^c MOSSAKOWSKI MEDICAL RESEARCH CENTRE   (Poland)

Author keywords

C reactive protein; Cytokines; Kidney transplantation; Periodontitis; Survival

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CREATININE; CYCLOSPORIN A; INTERLEUKIN 6; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; RAPAMYCIN; TACROLIMUS; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE SEVERITY; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERIODONTITIS; PRIORITY JOURNAL; RISK ASSESSMENT;

ADULT; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CHRONIC PERIODONTITIS; FEMALE; GRAFT SURVIVAL; HUMANS; INTERLEUKIN-6; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64349085833     PISSN: 09020063     EISSN: 13990012     Source Type: Journal    
DOI: 10.1111/j.1399-0012.2008.00931.x     Document Type: Article

References (39)

1. Dimeny EM. Cardiovascular disease after renal transplantation. Kidney Int 2002: 61: 78.
2. Ross R,G lomset JA. The pathogenesis of atherosclerosis (first of two parts). N Engl J Med 1976: 295: 369.
3. Ross R, Glomset JA. The pathogenesis of atherosclerosis (second of two parts). N Engl J Med 1976: 295: 420.
4. Bassuk SS, Rifai N, Ridker PM. High-sensitivity C-reactive protein: clinical importance. Curr Probl Cardiol 2004: 29: 439.
5. Rattazzi M, Puato M, Faggin E, Bertipaglia B, Zambon A, Pauletto P. C-reactiveprotein and interleukin-6 in vascular disease: Culprits or passive bystanders? J Hypertens 2003: 21: 1787.
6. Tracey KJ, Cerami A. Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Ann Rev Med 1994: 45: 491.
7. Ridker PM, Brown RJ, Vaughan DE, Harrison DG, Mehta JL. Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 2004: 109: IV6.
8. Jacobsson LT, Turesson C, Gulfe A et al. Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis. J Rheumatol 2005: 32: 1213.
9. Bennet AM, van Maarle MC, Hallqvist J et al. Association of TNF-alpha serum levels and TNFA promoter polymorphisms with risk of myocardial infarction. Atherosclerosis 2006: 187: 408.
10. Ganapathi MK, May LT, Schultz D et al. Role of interleukin 6 in regulating synthesis of C-reactive protein and serum amyloid A in human hepatoma cell lines. Biochem Biophys Res Commun 1988: 157: 271.
11. Marnell L, Mold C, Du Clos TW. C-reactive protein: Ligands, receptors and role in inflammation. Clin Immunol 2005: 117: 104.
12. Corrado E, Rizzo M, Tantillo R et al. Markers of inflammation and infection influence the outcome of patients with baseline asymptomatic carotid lesions. A 5-year follow-up study. Stroke 2006: 37: 482.
13. Pearson TA, Mensah GA, Alexander RW et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: A statement for healthcare professionals from the centers for disease control and prevention and the American Heart Association. Circulation 2003: 107: 499.
14. Meurman JH, Sanz M, Janket SJ. Oral health, atherosclerosis and cardiovascular disease. Crit Rev Oral Biol Med 2004: 15: 403.
15. Bodet C, Chandad F, Grenier D. Porphyromonas gingivalis-induced inflammatory mediator profile in an ex vivo human whole blood model. Clin Exp Immunol 2006: 143: 50.
16. Lin SJ, Chen YL, Kuo MY, Li CL, Lu HK. Measurement of gp130 cytokines oncostatin M and IL-6 in gingival crevicular fluid of patients with chronic periodontitis. Cytokine 2005: 30: 160.
17. Kurtis B, Tuter G, Serdar M et al. Gingival crevicular fluid levels of monocyte chemoattractant protein-1 and tumor necrosis factor-alpha in patients with chronic and aggressive periodontitis. J Periodontol 2005: 76: 1849.
18. Hujoel PP, White BA, Garcia MI, L istgarten MA. The dentogingival epithelial surface area revisited. J Periodontal Res 2001: 36: 48.
19. Ainamo J, Barmes D, Beagrie G, Cutress T, Martin J, Sardo-Infirri J. Development of the World Health Organization (WHO) Community Periodontal Index of Treatment Needs (CPITN). Int Dent 1982: 32: 281.
20. Franek E, Blach A, Wituła A et al. Association between chronic periodontal disease and left ventricular hypertrophy in kidney transplant recipients. Transplantation 2005: 80: 3.
21. Franek E, Blaschyk R, Kolonko A et al. Chronic periodontitis in hemodialyzed patients with chronic kidney disease is associated with elevated serum CRP concentration and greater intima-media thickness of the carotid artery. J Nephrol 2006: 19: 346.
22. Craig RG, Yip JK, So MK, Boylan RJ, Socransky SS, Haffajee AD. Relationship of destructive periodontal disease to the acute-phase response. J Periodontol 2003: 74: 1007.
23. Mattila K, Vesanen M, Valtonen V et al. Effect of treating periodontitis on C-reactive protein levels: A pilot study. BMC Infect Dis 2002: 2: 30.
24. Ide M, Jagdev D, Coward PY, Crook M, Barclay GR, Wilson RF. The short-term effects of treatment of chronic periodontitis on circulating levels of endotoxin, C-reactive protein, tumor necrosis factor-alpha, and interleukin-6. J Periodontol 2004: 75: 420.
25. Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F. Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension 2000: 35: 580.
26. Yeh ET. High-sensitivity C-reactive protein as a risk assessment tool for cardiovascular disease. Clin Cardiol 2005: 28: 408.
27. Honda H, Qureshi AR, Heimburger O et al. Serum albumin, C-reactive protein, interleukin 6 and fetuin a as predictors of malnutrition, cardiovascular disease and mortality in patients with ESRD. Am J Kidney Dis 2006: 47: 139.
28. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relation of plasma high sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003: 167: 73.
29. Chen CC,C hangKL, Huang JF, Tsai CC. Correlation of interleukin-1 beta, interleukin-6 and periodontitis. J Med Sci 1997: 13: 609.
30. Cueto-Manzano AM, Morales-Buenrostro LE, Gonzalez-Espinoza L et al. Markers of inflammation before and after renal transplantation. Transplantation 2005: 80: 47.
31. Tang S, LeungJC, Chan LY et al. Mycophenolate mofetil alleviates persistent proteinuria in IgA nephropathy. Kidney Int 2005: 68: 802.
32. Hurst SM, Wilkinson TS, McLoughlin RM et al. IL-6 and its soluble receptor orchestrate a temporal switch in the pattern of leukocyte recruitment seen during acute inflammation. Immunity 2001: 14: 705.
33. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V. Inflammation, obesity, stress and coronary heart disease: Is interleukin-6 the link? Atherosclerosis 2000: 148: 209.
34. Holla LI, Fassmann A, Stejskalova A, Znojil V, Vanek J, Vacha J. Analysis of the interleukin-6 gene promoter polymorphisms in Czech patients with chronic periodontitis. J Periodontol 2004: 75: 30.
35. Ferrari SL, Ahn-Luong L, Garnero P, Humphries SE, Greenspan SL. Two promoter polymorphisms regulating interleukin-6 gene expression are associated with circulating levels of C-reactive protein and markers of bone resorption in postmenopausal women. J Clin Endocrinol Metab 2003: 88: 255.
36. Vickers MA, Green FR, Terry C et al. Genotype at a promoter polymorphism of the interleukin-6 gene is associated with baseline levels of plasma C-reactive protein. Cardiovasc Res 2002: 53: 1029.
37. Espinoza M, Aguilera A, Auxiliadora Bajo M et al. Tumor necrosis factor alpha as a uremic toxin: Correlation with neuropathy, left ventricular hypertrophy, anemia, and hypertriglyceridemia in peritoneal dialysis patients. Adv Perit Dial 1999: 15: 82.
38. Mann DL, Bristow MR. Mechanisms and models in heart failure: The biomechanical model and beyond. Circulation 2005: 111: 2837.
39. Kapadia SR, Yakoob K, Nader S, Thomas JD, Mann DL, Griffin BP. Elevated circulating levels of serum tumor necrosis factor-alpha in patients with hemodynamically significant pressure and volume overload. J Am Coll Cardiol 2000: 36: 208.